Make Informed Investment Decisions with Affordable Access to Experts
A 7th Perspective: Discussing GBT's recent Sickle Cell Phase 3 HOPE Results for Voxelotor (Previously GBT440)Ticker(s): GBT, Emmaus Life Sciences
Name: Dr Susan Claster - MD
Institution: UC Irvine
- Clinical Professor, Medicine and Hematologist at UC Irvine.
- Currently manages 60 patients with sickle cell disease.
- Research interest in health outcomes for sickle cell disease; she specializes in benign hematology, including anemia, sickle cell disease, autoimmune diseases, clotting and blood disorders, and low platelets.
Please describe your background and experience with Sickle Cell Disease and any work with Voxelotor.Added By: c_admin
What is your high level opinion of today's top-line HOPE trial data?Added By: c_admin
On a scale of 1-10 how excited about this program are you for patients?Added By: c_admin
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.